• Maqsood Ahmed Khan university of karachi and ziauddin university
  • Syed Baqir Shyum Naqvi Hamdard University
  • Shazia Alam Ziauddin University
  • Syed Imran Ali Ziauddin University
  • Mehwish Rizvi Ziauddin University
  • Mudassar Hussain University of Karachi
  • Syed Monis Jawed University of Karachi Sindh


Community-acquired pneumonia (CAP) and Antibiotics


Objective: Community-acquired pneumonia (CAP) is a potentially serious infection that results in various general physicians (GP) visits and hospital admission every year. The prime objective of this research was to find the current trend of treatment of community-acquired pneumonia in Karachi.

Methods: It was a prospective survey conducted in all districts of Karachi. A Questionnaire was filled by distinctive specialities of doctors in an outpatient setting in Karachi. A preliminary test questionnaire was used to collect the data directly from distinctive specialities of doctors in outpatient setting in Karachi. Total 500 doctors were selected from distinct districts of Karachi with convenient random sampling.

Results: Majority (33.8%) of the respondents recommended complete blood count and chest x-ray for diagnosis of community-acquired pneumonia in an outpatient setting. Most (76%) of the respondents recommended nebulization for the management of community-acquired pneumonia in an outpatient setting. 31% and 25.4% of the physicians recommended clarithromycin as 1st line antibiotic therapy in adults and children for the management of a community-acquired pneumonia patients in outpatient setting.55.6% of the physicians recommended two-week duration of antibiotic therapy for the management of CAP in outpatient setting.

Conclusion: This is clearly indicated by this study that deviation from the standard guideline is observed in the management of community-acquired pneumonia in Karachi. These deviations from the highly recommended guideline can results excess cost and inappropriateness of the management of the disease of community-acquired pneumonia. There is a need that the physician should take a decision of therapy according to the standard guidelines for the treatment of CAP in an outpatient setting.



Download data is not yet available.

Author Biography

Maqsood Ahmed Khan, university of karachi and ziauddin university

 faculty of pharmacy ziauddin university 

department of pharmacy practice


Gleason PP, Kapoor WN, Stone RA. Medical outcomes and antimicrobial costs with the use of the American thoracic society guidelines for outpatients with community-acquired pneumonia. JAMA 1997;278:32–9.

Marrie TJ. Community-acquired pneumonia. Clin Infect Dis 1994;18:501–15.

Almirall J, Bolíbar I, Vidal J, Sauca G, Coll P, Niklasson B, et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 2000;15(4):757-63.

Guest JF, Morris A. Community-acquired pneumonia: the annual cost to the National Health Service in the UK. Eur Respir J1997;10:1530-4.

Fantin B, Aubert JP, Unger P, Lecoeur H, Carbon C. Clinical evaluation of the management of community-acquired pneumonia by general practitioners in france. CHEST 2001;120(1);185-92.

Feagan BG, Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK. Treatment and outcomes of community-acquired pneumonia at Canadian hospitals. Can Med Assoc J 2000;162(10):1415-20.

McCormick D, Fine MJ, Coley CM, Marrie TJ, Lave JR, Obrosky DS, et al. Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes? Am J Med 1999;107(1):5-12.

Ortqvist A. Antibiotic treatment of community-acquired pneumonia in clinical practice: a European survey. J Antimicrob Chemother 1995;35:205-12.

Nathwani D, Rubinstein E, Barlow G, Davey P. Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care? Clin Infect Dis 2001;32:728-41.

Rhew DC, Goetz MB, Shekelle PG. Evaluating quality indicators for patients with community-acquired pneumonia. J Qual Improv 2001;27:575-90.

Jenks SF, Wilensky GR. The health care quality improvement initiative. J Am Med Assoc 1992;268:900-3.

Macfarlane J. BTS Guidelines for the management o f community acquired pneumonia in adults. Thorax 2001;56 Suppl 4: iv1-iv64.

Hussain H, Naqvi SB, Khan MA, Rizvi M, Alam S, Abbas A, et al. Direct cost of treatment of diabetes mellitus in Pakistan 2014;6:11.

Jamshed SQ, Ibrahim MIM, Hassali MA, Masood I, Low BY, Shafie AA, et al. Perception and attitude of general practitioners regarding generic medicines in Karachi, Pakistan: A questionnaire based study. Southern Med Rev 2012;(5)1:22-30.

Husain SA, Javaid A, Basit A, Ziaullah, Islam MS, Sarfaraz S, et al. study of current management of community acquired pneumonia and strategies for improvement. JPMI 2008;22(02):107:12.

Krueger P, Loeb M, Kelly C, Edward HG. Assessing, treating and preventing community acquired pneumonia in older adults: findings from a community-wide survey of emergency room and family physicians. BMC Family Practice 2005;6:32.

Rosh AJ, Newman DH. Diagnosing pneumonia by medical history and physical examination. Ann Emerg Med 2005;46(5):465-7.

Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. infectious diseases society of america: american thoracic society consensus guidelines on the management of community-acquired pneumonia. Clin infect Dis 2007;44 Suppl 2:S27-72.

Brady SA, Byington CL, Shah SS, Alversion B, Carter ED, Harrison C, et al. The management of community –acuired pneumonia in infants and children older than 3 months of age: Clinical practice guidelines by the pediatric infectious Disease Society and the infectious disease Society of America. Clin Infect Dis 2011:53(7):617-30.

Kamangar N. bacterial pneumonia treatment and management Medscape; 2014.

Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune, et al. BTS guidelines for the management of community acquired pneumonia in adults: update. Thorax 2009; 64 Suppl 3:iii1-55.

Ashraf H, Alam NH, Chisti MJ, Salam MA, Ahmed T, Gyr N. Observational follow-up study on a cohort of children with severe pneumonia after discharge from a day-care clinic in Dhaka. Bangladesh J Health Popul Nutr 2014;32(2):183-9.

Laurichesse H, Robin F, Gerbaud L, Pochet P, Gourdon F, Beytout J, et al. Empirical therapy for non hospitalized patients with community-acquired pneumonia. study group of general practioner. Eur Respir J 1998;11:73–8.

Mac Dougall C, Guglielmo BJ, Maselli J, Gonzales R. Antimicrobial Drug Prescribing for Pneumonia in Ambulatory Care. Emerging Infect Dis 2005;11(3):380-4.

Carrie AG, Kozyrskyj AL. Disease, temporal and sociodemographic influences on initial treatment of community acquired pneumonia in Manitoba. Canada Int J Antimicrob Agents 2006;28(2):95-100.

Dorj G, Hendrie D, Parsons R, Sunderland B. An evaluation of prescribing practices for community-acquired pneumonia (CAP) in Mongolia. BMC Health Services Res 2013;13:379.

Kronman MP, Hersh AL, Feng R, Huang YS, Lee GE, Shah SS. Ambulatory visit rates and antibiotic prescribing for children with pneumonia 1994-2007. Pediatrics 2011;127(3):411-8.

Bartolomé M, Almirall J, Morera J, Pera G, Ortún V, Bassa J, et al. Maresme community-acquired pneumonia study group (GEMPAC) A population-based study of the costs of care for community-acquired Pneumonia. Eur Respir J 2004;23:610–6.



How to Cite

Khan, M. A., S. B. S. Naqvi, S. Alam, S. I. Ali, M. Rizvi, M. Hussain, and S. M. Jawed. “SURVEY BASE STUDY ON CURRENT TREND OF TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN KARACHI”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 4, Apr. 2015, pp. 162-7,



Original Article(s)